Clinical features associated with treatment-resistant pediatric obsessive-compulsive disorder

被引:49
|
作者
Storch, Eric A. [1 ,2 ]
Merlo, Lisa J. [1 ]
Larson, Michael J. [3 ]
Marien, Wendi E. [1 ]
Geffken, Gary R. [1 ,2 ]
Jacob, Marni L. [1 ]
Goodman, Wayne K. [1 ]
Murphy, Tanya K. [1 ]
机构
[1] Univ Florida, Dept Psychiat, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA
[3] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA
关键词
D O I
10.1016/j.comppsych.2007.06.009
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The objective of the study was to identify clinical and sociodemographic characteristics that may differentiate youth with obsessive-compulsive disorder (OCD) who are resistant to treatment vs those who have a favorable response. Method: Participants included 60 outpatients, aged 7-17 years, who were determined to have previously received an adequate trial of a first-line treatment (ie, serotonin reuptake inhibitors, cognitive behavioral therapy). Patients who were treatment-resistant were compared with responders on a number of factors, including severity and nature of OCD symptoms, levels of internalizing and extemalizing symptoms, family accommodation of OCD symptoms, and functional impairment. Results: The treatment-resistant group endorsed significantly more obsessions and compulsions, greater levels of internalizing symptoms, higher parental stress related to accommodation, and greater functional impairment than treatment responders. However, relative to treatment-resistant patients, treatment responders reported higher levels of depressive symptoms, perhaps indicating that they were more distressed by their OCD symptoms, as well as greater insight into their symptoms. Conclusions: This study indicates that youth with more severe symptoms of OCD, higher related parental stress, and greater functional impairment tend to be more resistant to first-line treatments, and that perhaps they may require more intensive or family-based interventions. Treatment responders report more depressive symptoms and insight into their OCD, which may suggest a greater readiness for treatment. Further research likely would help to identify which types of treatment would be most beneficial for individual youth. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [21] Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder
    Oulis, Panagiotis
    Mourikis, Iraklis
    Konstantakopoulos, George
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2011, 26 (04) : 221 - 224
  • [22] Clinical features associated with treatment response in obsessive-compulsive disorder
    Shavitt, Roseli G.
    Belotto, Cristina
    Curi, Mariana
    Hounie, Ana G.
    Rosario-Campos, Maria C.
    Diniz, Juliana B.
    Ferrao, Ygor A.
    Pato, Michele T.
    Miguel, Euripedes C.
    COMPREHENSIVE PSYCHIATRY, 2006, 47 (04) : 278 - 283
  • [23] Primary Sjogren's Syndrome Associated With Treatment-Resistant Obsessive-Compulsive Disorder
    Ong, Lawrence T. C.
    Galambos, Gary
    Brown, David A.
    FRONTIERS IN PSYCHIATRY, 2017, 8
  • [24] Trauma and posttraumatic stress disorder in treatment-resistant obsessive-compulsive disorder
    Gershuny, Beth S.
    Baer, Lee
    Parker, Holly
    Gentes, Emily L.
    Infield, Alison L.
    Jenike, Michael A.
    DEPRESSION AND ANXIETY, 2008, 25 (01) : 69 - 71
  • [25] Treatment-resistant obsessive-compulsive disorders
    Endres, Dominique
    Jelinek, Lena
    Domschke, Katharina
    Voderholzer, Ulrich
    NERVENARZT, 2024, 95 (05): : 432 - 439
  • [26] Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder
    Hollander, E
    Dell'Osso, B
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (03) : 189 - 191
  • [27] Antipsychotics in treatment-resistant obsessive-compulsive disorder - a systematic review
    Dold, M.
    Lanzenberger, R.
    Aigner, M.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2010, 14 : 23 - 23
  • [28] Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder
    Fontenelle, LF
    Mendlowicz, MV
    Miguel, EC
    Versiani, M
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2005, 6 (01): : 57 - 59
  • [29] Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder
    Walsh, KH
    McDougle, CJ
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (10) : 2059 - 2067
  • [30] Lumateperone monotherapy for treatment-resistant obsessive-compulsive disorder in an adolescent
    Naguy, Ahmed
    Pridmore, Saxby
    Abuzeid, Mohamed Y.
    Elsori, Dalal
    Alamiri, Bibi
    CNS SPECTRUMS, 2024, 29 (01) : 4 - 5